ArticleHeliyon2023

Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients.

Daniele Lavacchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.